These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome. Tucker HS; Lankford HV; Gardner DF; Blackard WG J Clin Endocrinol Metab; 1980 Nov; 51(5):968-71. PubMed ID: 6775003 [TBL] [Abstract][Full Text] [Related]
4. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea. Dickey RP; Stone SC Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580 [TBL] [Abstract][Full Text] [Related]
5. Bromocryptine therapy in cases of amenorrhea-galactorrhea. Mroueh AM; Siler-Khodr TM Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea. Aono T; Shioji T; Kohno M; Ueda G; Kurachi K Fertil Steril; 1976 Mar; 27(3):341-4. PubMed ID: 943332 [TBL] [Abstract][Full Text] [Related]
8. Effect of triiodothyronine treatment on prolactin secretion in patients with amenorrhea-galactorrhea. Aono T; Shioji T; Miyai K; Onishi T; Kurachi K J Clin Endocrinol Metab; 1977 Jan; 44(1):8-14. PubMed ID: 401825 [TBL] [Abstract][Full Text] [Related]
9. [Study on galactorrhea-amenorrhea syndrome (GAS) with special reference to normoprolactinemic GAS]. Imai T; Yasuda K; Miura K Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):1-15. PubMed ID: 3132404 [TBL] [Abstract][Full Text] [Related]
10. Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea. MacGregor C; Maldonado D; Canales ES; Soria J; Zárate A Acta Obstet Gynecol Scand; 1977; 56(4):333-6. PubMed ID: 414510 [TBL] [Abstract][Full Text] [Related]
11. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine. Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432 [TBL] [Abstract][Full Text] [Related]
12. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea. March CM; Kletzky OA; Davajan V Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198 [TBL] [Abstract][Full Text] [Related]
13. Treatment of functional amenorrhea-galactorrhea with 2-bromoergocryptine. Wiebe RH; Hammond CB; Handwerger S Fertil Steril; 1977 Apr; 28(4):426-33. PubMed ID: 321260 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin. Tyson JE; Khojandi M; Huth J; Smith B; Thomas P Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151 [TBL] [Abstract][Full Text] [Related]
15. Galactorrhea-amenorrhea syndromes: etiology and treatment. Spark RF; Pallotta J; Naftolin F; Clemens R Ann Intern Med; 1976 May; 84(5):532-7. PubMed ID: 945033 [TBL] [Abstract][Full Text] [Related]
16. Pregnancy following thyroid hormone treatment in a patient with amenorrhea-galactorrhea due to primary hypothyroidism. Aono T; Shioji T; Onishi T; Kurachi H; Miyai K Fertil Steril; 1977 Aug; 28(8):878-80. PubMed ID: 885277 [TBL] [Abstract][Full Text] [Related]
17. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment. Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619 [TBL] [Abstract][Full Text] [Related]